NASDAQ:PCVX
Vaxcyte, Inc.
- Stock
Last Close
64.55
03/05 20:00
Market Cap
6.12B
Beta: 0.96
Volume Today
609.85K
Avg: 962.38K
PE Ratio
−25.01
PFCF: −32.24
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -29.48M - | -50.27M 70.51% | -89.22M 77.46% | -100.08M 12.17% | -223.49M 123.31% | -402.27M 80.00% | |
depreciation and amortization | 1.04M - | 1.23M 18.80% | 1.41M 14.04% | 3.46M 146.05% | 9.20M 166.01% | 10.17M 10.60% | |
deferred income tax | 51K - | 1K 98.04% | 301K 30,000% | -11.22M - | |||
stock based compensation | 749K - | 1.19M 58.21% | 5.43M 358.57% | 10.73M 97.44% | 23.65M 120.43% | 48.76M 106.17% | |
change in working capital | 1.90M - | 3.91M 106.23% | 35.27M 802.51% | -37.01M 204.92% | 12.74M 134.42% | 81.32M 538.45% | |
accounts receivables | 1.27M - | 868K 31.44% | |||||
inventory | -1.19M - | 2.87M 341.79% | |||||
accounts payables | 1.27M - | 868K 31.44% | 26.10M 2,907.14% | -12.47M 147.77% | 2.90M 123.22% | 11.22M 287.60% | |
other working capital | 550K - | -698K 226.91% | 9.17M 1,413.47% | -24.54M 367.62% | 9.84M 140.11% | 70.09M 612.28% | |
other non cash items | -4.71M - | -3.20M 32.17% | 179K 105.60% | 1.50M 739.66% | 7.30M 386.03% | -23.55M 422.38% | |
net cash provided by operating activities | -30.47M - | -47.15M 54.75% | -46.63M 1.10% | -121.39M 160.34% | -170.60M 40.53% | -296.79M 73.97% | |
investments in property plant and equipment | -1.77M - | -1.20M 32.64% | -1.16M 3.35% | -6.55M 467.53% | -5.85M 10.79% | -67.88M 1,060.69% | |
acquisitions net | 50K - | 26K 48% | 7K 73.08% | 51.81M 740,114.29% | |||
purchases of investments | -336.34M - | -102.75M 69.45% | -1.33B 1,194.37% | ||||
sales maturities of investments | 130.56M - | 183.17M 40.29% | 624.46M 240.92% | ||||
other investing activites | 1K - | -51.81M - | |||||
net cash used for investing activites | -1.77M - | -1.20M 32.60% | -1.10M 7.53% | -212.31M 19,113.39% | 74.58M 135.13% | -773.31M 1,136.82% | |
debt repayment | -283K - | -278K 1.77% | -61K 78.06% | ||||
common stock issued | 42.94M - | 267.38M 522.64% | 13.90M 94.80% | 856.48M 6,063.50% | 643.69M 24.84% | ||
common stock repurchased | 374K - | 888K 137.43% | 1.03M 16.33% | 2.04M 97.29% | |||
dividends paid | -374K - | ||||||
other financing activites | 62.47M - | -1.10M 101.76% | 107.56M 9,904.56% | 3.01M 97.20% | 4.03M 33.93% | -5.91M 246.60% | |
net cash used provided by financing activities | 62.19M - | 41.57M 33.16% | 374.87M 801.85% | 17.80M 95.25% | 861.55M 4,741.24% | 639.81M 25.74% | |
effect of forex changes on cash | -341K - | 87K 125.51% | -439K 604.60% | 137K 131.21% | -6.69M 4,980.29% | ||
net change in cash | 29.95M - | -7.11M 123.75% | 327.22M 4,699.72% | -316.34M 196.68% | 765.67M 342.04% | -437.21M 157.10% | |
cash at beginning of period | 36.14M - | 66.09M 82.88% | 58.98M 10.76% | 386.20M 554.84% | 69.86M 81.91% | 834.66M 1,094.83% | |
cash at end of period | 66.09M - | 58.98M 10.76% | 386.20M 554.84% | 69.86M 81.91% | 835.53M 1,096.07% | 397.45M 52.43% | |
operating cash flow | -30.47M - | -47.15M 54.75% | -46.63M 1.10% | -121.39M 160.34% | -170.60M 40.53% | -296.79M 73.97% | |
capital expenditure | -1.77M - | -1.20M 32.64% | -1.16M 3.35% | -6.55M 467.53% | -5.85M 10.79% | -67.88M 1,060.69% | |
free cash flow | -32.24M - | -48.34M 49.94% | -47.78M 1.15% | -127.95M 167.77% | -176.44M 37.90% | -364.67M 106.67% |
All numbers in USD (except ratios and percentages)